Introduction
Haemopoietic dysplasia is not a rare clinical problem; it has been said to occur with a frequency of 2 cases for every 5 of overt leukaemia (Linman and Bagby, 1976) . Nevertheless, such cases are commonly a source of difficulty in diagnosis and management for the clinician, and result in extensive and unnecessary investigations for the patient. Some of this difficulty stems from the variety of names which are applied to the condition; pre-leukaemia, smouldering leukaemia, refractory anaemia with excess myeloblasts, and stem cell dysplasia are not the only examples.
The term haemopoietic dysplasia is used here to describe a chronic bone marrow disorder characterized by distinctive abnormalities in all myeloid compartments but without sufficient increase in blast cells for a diagnosis of acute leukaemia( < 10%).
Symptoms and physical findings lack specificity, but haematological manifestations are remarkably constant. In a review of 132 cases Linman and Bagby (1976) found that males over 50 years were most commonly affected. (Dacie et al., 1959) , decreased neutrophil alkaline phosphatase (Dacie et al., 1959) , reduced capacity of bone marrow cells to form granulocytic colonies in vitro (Editorial, 1973) , chromosomal abnormalities (Rowley, Blaisdell and Jacobson, 1966) , and platelet function abnormalities (Sultan and Caen, 1972) . The majority of these patients eventually develop acute leukaemia; in one study 71%o in less than 2 years and the remaining 29% within 9 years (Linman and Bagby, 1976) . A patient has been described in whom there was a pre-leukaemic phase of 20 years (Catovsky et al., 1971) . Haemopoietic dysplasia can, however, be a cause of mortality in itself; and in a further series (Dreyfus, 1976) 
Materials and methods
Neutrophil function was assessed on the basis of the ability of these cells to phagocytose and kill a species of Candida (C. guilliermondi). The method was described by El-Maalem and Fletcher (1976) . Essentially, peripheral blood neutrophils at a concentration of 9 x 106/ml are incubated with an equal volume of Candida at a concentration of 4 x 107 organisms/ml in 199TC at 37°C. The mixture is sampled at 15 and 90 min, and slides prepared with a cytocentrifuge. The preparations are then stained with Leishman and for myeloperoxidase (Kaplow, 1965 Peripheral blood neutrophils were also scored for alkaline phosphatase (Dacie and Lewis, 1975) . Patients 1, 2 and 3 score 0, 70 and 200 respectively compared with 52, 64 and 78 for 3 controls.
Discussion
Many patients with haemopoietic dysplasias develop severe or lethal infections in the absence of blastic proliferation, and these patients often possess normal numbers of neutrophils (Dreyfus, 1973) . There have been several previous reports of defective function of these neutrophils in vitro. Ruutu et al. (1977) detected a cellular defect in chemotaxis in three patients, but the majority of these reports (Lehrer et al., 1972; Breton-Gorius, Houssay and Dreyfus, 1975a,b; Davis, Brunning and Quinn, 1971) have shown a marked deficiency of myeloperoxidase as the cause of impaired bactericidal activity. One report (Breton-Gorius et al., 1975b) however, did describe a patient with variation in the myeloperoxidase content of the azurophilic granules of his peripheral blood neutrophils. In those neutrophils which contained the enzyme the granules appeared not to fuse with the phagocytic vacuole.
In each of the 3 patients in the present study the myeloperoxidase content of the azurophils was comparable to that of normal controls, and the reason for impaired microbiocidal activity appeared to be defective degranulation. This is similar to the results observed, using the same system, for the neutrophils of patients with chronic granulocytic leukaemia (El-Maalem and Fletcher, 1976 Linman, 1973) , and the cause of death, in the absence of acute leukaemia, in almost 50/o (Dreyfus, 1976) . As already stressed, these patients are often not neutropenic. Two of the 3 above patients had severe infective problems, and the peripheral blood of case 2 always showed increased numbers of neutrophils.
The most important point in the management of these patients is the achievement of an early firm diagnosis, based on the criteria already discussed. The patient is then spared from lengthy, expensive and often frightening investigation, which unfortunately they have often to endure. Simple light microscopy of blood and bone marrow is the most It is now generally agreed that management should be conservative with close observation and specific treatment of clinically significant or life-threatening manifestations such as severe anaemia or infections if they occur. There is an isolated report of complete remission with cytotoxic drugs (Linman and Bagby, 1976) , but in view of present inability to predict the time when evolution to full blown leukaemia may occur (up to 20 years), these are usually reserved until the marrow becomes packed with blast cells.
